![]() |
Pediatric Medications Administrations |
````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````
| Pharmacokinetics | ||||
| Administration | ||||
| Physiologic attributes | ||||
| Pharmacokinetics in infants | ||||
| Pharmacokinetics in children | ||||
| Pediatric Medication Calculations | ||||
| Developmental Considerations | ||||
| Reaction to Pain |
| Administering medications to the pediatric population includes knowledge of: |
|
||||||||||||
|
Pharmacokinetics: Is the study of the concentration of a drug within the body during the process of absorption, distribution, metabolism and excretion. |
Absorption is the process that involves drug movement from the site of entry in the body to the blood stream. Distribution is the transport of the the drug in body fluids from the bloodstream to the tissues of the body. Distribution is effected by body water content, body fat content, and plasma protein levels. Metabolism is the process by which drugs are chemically inactivated so that they can be excreted. Excretion is the process whereby metabolized drugs are removed from their sites of action and eliminated by the body.
|
||||||||||||
| Serum drug levels: Monitoring serum levels help to determine appropriate dosage, scheduling, and route of administration. | Determine if drug levels are reaching toxicity levels.
Determine if drug level is to low for therapeutic response. Peak and trough levels help to determine if drug is in the desired range for therapeusis and safety. Peak level is the highest concentration a drug reaches after a number of doses have been administered. Trough level is the lowest concentration a drug reaches between doses. Therapeutic Index (TI) is the concentration of a drug necessary to produce the desired therapeutic effect without causing toxicity. Steady state: Steady state concentration of a drug refers to the state in which the drugs distribution is in equilibrium with the body. The amount of the drug taken in is equal to the amount of the drug excreted. Loading dose is a relatively high dose used with some drugs to start therapy to shorten the length of time it takes to read a steady state concentration. Once a loading dose has been given, the drug dose is decreased to the maintenance dose and given on a regular schedule. |
||||||||||||
| Drug dosing in infants and
children. Recommended doses for FDA approved drugs must be computed
based on the individual child's weight.
Accurate drug dose is critical since infants / children doe not have the mature physiological responses to compensate for drug errors. |
Two methods of calculating pediatric dosage are:
The mg/kg formula will be used during the pediatric rotation for calculating accurate drug dosages for the pediatric patient.
|
||||||||||||
| Cognitive and psychosocial developmental considerations | Developmental age is the functioning level of the child.
Strategies consistent with the child's developmental are needed to ensure safe and effective medication administration. Assessing the child's temperament can led to determining best method of administering a medication. General guidelines for administration of medications to pediatric patient include:
|
Rate of Drug Absorption by Route of Administration
| Route of Administration | Absorption Characteristics | ||||||||
| Enteral
Parenteral
Inhalation
Rectal
Sublingual, Buccal
Topical
|
Subcutaneous Absorption is rapid in aqueous solutions. Absorption is slower in oily preparations. Intramuscular Absorption rapid due to increased blood flow. Intravenous Absorption is immediate due t direct injection into the blood stream. Intrathecal Absorption is rapid in the CNS due to bypass of blood brain barrier.
Absorption is rapid due to large surface area of lungs. Vascularity of lungs promotes ready entry into the blood stream.
Absorption is generally erratic.
Absorption is rapid and complete as long as tablet is retained at administration site.
Absorption is erratic but more complete in children due to smaller body surface area |
Physiologic Attributes of Infants and Implications for Drug Therapy.
| Attribute | Implication |
| Increased total body water.
Increased membrane permeability, skin and blood-brain barrier. Decreased body fat. Immature kidney, liver function. Immature temperature regulation |
Increased distribution of drug, decreased blood levels of
water-soluble drugs.
Increased CNS distribution and likelihood of neurotoxicity, enhanced topical absorption. Increased absorption of fat-soluble drugs. Prolonged excretion or metabolism of certain drugs. May dehydrate readily, increasing concentration of drugs.
|
Adapted from Shlafer: The nurse, pharmacology, and drug therapy, Menlo Park, California, 1993, The Benjamin/Cummings Publishing Company.
![]() |
Absorption
Rates of drug absorption in the infant are lower than absorption rates in children and adults. Prolonged gastric transit time and variable gastric pH lead to diminished absorption. Frequent feeding may impede drug absorption. Low levels of intestinal flora and reduced enzyme function can led to decreased absorption. Low peripheral perfusion and immature heat regulation can decrease absorption of IV, IM, or SC medications. |
| Distribution
Low concentration of plasma proteins and diminished protein-binding capacity allow drugs to be more available in the circulation. Greater permeability of the blood-brain barrier, allows for rapid access of drugs to the CNS. Total Body water is 80% compared to the adult 50%. Higher doses of water soluble drugs may be needed to achieve therapeutic effects. |
Metabolism
Drug-metabolizing enzymes in the the liver of infants are immature. More drugs in circulatory system may increase potential for drug toxicity. Drug dosages for infants must be calculated carefully and drug levels and clinical responses closely monitored. Excretion Infant kidneys have higher resistance to blood flow, lower GFR with a decreased ability to concentrate urine. Infants may secrete drugs more slowly, increasing risk of drug accumulation.
|
![]() |
Absorption
Gastric pH equal to adult by 2 to 3 years of age. Gastric emptying rates are faster than infants. Skin and blood-brain barrier become more effective. Distribution Plasma proteins reach adult levels by age 1. Children up to age 2 years of age may require higher dosages of water-soluble drugs. |
| Metabolism
Liver enzymes are more effective at metabolizing drugs. Due to elevated BMR some drugs are metabolized more rapidly. Drug dosages relative to body weight may need to be higher. Drugs may need to be more closely monitored.
|
Excretion
Children over 12 months of age are able to excrete drugs effectively. |
The developmental stage of a child affects how the child perceives and reacts to pain. The nurse needs to consider the child's developmental stage when assessing and managing pain in children.
| Neonate | Because motor pathways are poorly developed, neonates respond with generalized body movements and do not withdraw affected limb. |
| About 3 months | Infant begins to localize pain. |
| About 6 months | The infant can remember painful events in the past and associated past and current events. They may anticipate pain. |
| 13 to 14 months | Anticipatory distress continues. Goal directed movements to reduce pain appear, such as rubbing a painful site. Other indications of pain include irritability, restlessness, rigidity, lethargy, poor feeding, disturbed sleep, crying, tachycardia and respiratory distress. |
| Toddler | React to pain with intense emotion and resistance. They cannot comprehend the meaning of pain and often react with aggression such as biting, hitting, and temper tantrums. Reaction to pain is influenced by past memories, attachment to parents and physical restraint. |
| Preschool | They have egocentric fantasy, magical thinking and intense concern about body injury. Pain may be perceived as punishment. Nurses need to explain that pain is not related to the goodness of the child. |
| School age | They are able to describe pain. As the child gets older they are able to use more abstract terms to describe pain. The child attempts to master the pain and may use coping mechanisms similar to adults. |
| Adolescent | They often display self-control when in pain and may try to conceal the pain. However, they may not be able to deal with the underlying anxiety and the repressed emotional energy may lead to acting out. Showing concern, providing pain relief and providing control may help the adolescent cope with painful situations. |
Adapted from Morrison, H.M. (1991). Pain in the critically ill child. In: Puntillo, K.A. Pain in the critically ill: Assessment and Management. Gaithersburg, MD: Aspen Publishers, Inc.
![]() |
Developmental Age (1 month to 1 year)
|
||||||||||||
|
|
![]() |
Developmental Age (1 to 2 years)
|
||||||||||||||||
|
|
|||||||||||||||||
![]() |
Pre-School (3 to 6 years)
|
||||||||||||||||
|
|
|||||||||||||||||
![]() |
School Age (6 to 12 years)
|
||||||||||||||||
|
|
|||||||||||||||||
![]() |
Adolescent (12 to 18 years)
|
||||||||||||||||
|
|
Pediatric Medication Calculation
| Web links for administration of medication to children. | Liquid Medication Administration: Children's Hospital
Medical Center
http://www.fda.gov/fdac/features/196_kid.html
|
| Prevention of Medication Errors in the Pediatric Inpatient Setting | http://www.aap.org/policy/re9751.html
|
| Pediatric Medication Calculation with post-test.
|
http://www.accd.edu/sac/nursing/math/pedsmath.html
|
JCAHO Pain Standards
| Health providers are expected to be knowledgeable
about pain assessment and management, and facilities are expected to
develop policies and procedures supporting the appropriate assessment of
pain and the use of analgesics and other pain control interventions. Some
key concepts are:
|
( JBCRN, 2006)